These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
487 related articles for article (PubMed ID: 33491499)
1. A proteogenomic approach to target neoantigens in solid tumors. Verma A; Halder A; Marathe S; Purwar R; Srivastava S Expert Rev Proteomics; 2020; 17(11-12):797-812. PubMed ID: 33491499 [TBL] [Abstract][Full Text] [Related]
2. Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapy. Ren Y; Yue Y; Li X; Weng S; Xu H; Liu L; Cheng Q; Luo P; Zhang T; Liu Z; Han X Int Immunopharmacol; 2024 Dec; 142(Pt A):113147. PubMed ID: 39270345 [TBL] [Abstract][Full Text] [Related]
3. ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection. Li Y; Wang G; Tan X; Ouyang J; Zhang M; Song X; Liu Q; Leng Q; Chen L; Xie L BMC Med Genomics; 2020 Apr; 13(Suppl 5):52. PubMed ID: 32241270 [TBL] [Abstract][Full Text] [Related]
4. Application of mass spectrometry-based MHC immunopeptidome profiling in neoantigen identification for tumor immunotherapy. Zhang X; Qi Y; Zhang Q; Liu W Biomed Pharmacother; 2019 Dec; 120():109542. PubMed ID: 31629254 [TBL] [Abstract][Full Text] [Related]
5. ProGeo-Neo v2.0: A One-Stop Software for Neoantigen Prediction and Filtering Based on the Proteogenomics Strategy. Liu C; Zhang Y; Jian X; Tan X; Lu M; Ouyang J; Liu Z; Li Y; Xu L; Chen L; Lin Y; Xie L Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627168 [TBL] [Abstract][Full Text] [Related]
6. Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors. Rivero-Hinojosa S; Grant M; Panigrahi A; Zhang H; Caisova V; Bollard CM; Rood BR Nat Commun; 2021 Nov; 12(1):6689. PubMed ID: 34795224 [TBL] [Abstract][Full Text] [Related]
7. Proteogenomic Platform for Identification of Tumor Specific Antigens. Faktor J; Hernychová L; Vojtěšek B; Hupp T Klin Onkol; 2018; 31(Suppl 2):102-107. PubMed ID: 31023032 [TBL] [Abstract][Full Text] [Related]
8. Proteogenomic analysis identifies neoantigens and bacterial peptides as immunotherapy targets in colorectal cancer. Yao P; Gao M; Hu W; Wang J; Wang Y; Wang Q; Ji J Pharmacol Res; 2024 Jun; 204():107209. PubMed ID: 38740147 [TBL] [Abstract][Full Text] [Related]
9. [Identification of neoantigens and development of antigen-specific immunotherapy]. Shinohara S; Takahashi Y; Demachi-Okamura A; Matsushita H Rinsho Ketsueki; 2020; 61(9):1433-1439. PubMed ID: 33162546 [TBL] [Abstract][Full Text] [Related]
10. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors. Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255 [TBL] [Abstract][Full Text] [Related]
11. Neoantigen vaccine: an emerging tumor immunotherapy. Peng M; Mo Y; Wang Y; Wu P; Zhang Y; Xiong F; Guo C; Wu X; Li Y; Li X; Li G; Xiong W; Zeng Z Mol Cancer; 2019 Aug; 18(1):128. PubMed ID: 31443694 [TBL] [Abstract][Full Text] [Related]
12. PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions. Tan X; Xu L; Jian X; Ouyang J; Hu B; Yang X; Wang T; Xie L Cells; 2023 Mar; 12(5):. PubMed ID: 36899918 [TBL] [Abstract][Full Text] [Related]
13. Challenges targeting cancer neoantigens in 2021: a systematic literature review. Chen I; Chen MY; Goedegebuure SP; Gillanders WE Expert Rev Vaccines; 2021 Jul; 20(7):827-837. PubMed ID: 34047245 [No Abstract] [Full Text] [Related]
14. Neoantigens in Hematological Malignancies-Ultimate Targets for Immunotherapy? Roerden M; Nelde A; Walz JS Front Immunol; 2019; 10():3004. PubMed ID: 31921218 [TBL] [Abstract][Full Text] [Related]
15. Neoantigen vaccine platforms in clinical development: understanding the future of personalized immunotherapy. Supabphol S; Li L; Goedegebuure SP; Gillanders WE Expert Opin Investig Drugs; 2021 May; 30(5):529-541. PubMed ID: 33641576 [TBL] [Abstract][Full Text] [Related]
17. Proteogenomics meets cancer immunology: mass spectrometric discovery and analysis of neoantigens. Polyakova A; Kuznetsova K; Moshkovskii S Expert Rev Proteomics; 2015; 12(5):533-41. PubMed ID: 26175083 [TBL] [Abstract][Full Text] [Related]
18. Engineering neoantigen vaccines to improve cancer personalized immunotherapy. Liu Z; Lv J; Dang Q; Liu L; Weng S; Wang L; Zhou Z; Kong Y; Li H; Han Y; Han X Int J Biol Sci; 2022; 18(15):5607-5623. PubMed ID: 36263174 [TBL] [Abstract][Full Text] [Related]
19. Tumor neoantigens: from basic research to clinical applications. Jiang T; Shi T; Zhang H; Hu J; Song Y; Wei J; Ren S; Zhou C J Hematol Oncol; 2019 Sep; 12(1):93. PubMed ID: 31492199 [TBL] [Abstract][Full Text] [Related]
20. Development of neoantigens: from identification in cancer cells to application in cancer vaccines. Ebrahimi N; Akbari M; Ghanaatian M; Roozbahani Moghaddam P; Adelian S; Borjian Boroujeni M; Yazdani E; Ahmadi A; Hamblin MR Expert Rev Vaccines; 2022 Jul; 21(7):941-955. PubMed ID: 34196590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]